CA2006529A1 - N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments - Google Patents
N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicamentsInfo
- Publication number
- CA2006529A1 CA2006529A1 CA2006529A CA2006529A CA2006529A1 CA 2006529 A1 CA2006529 A1 CA 2006529A1 CA 2006529 A CA2006529 A CA 2006529A CA 2006529 A CA2006529 A CA 2006529A CA 2006529 A1 CA2006529 A1 CA 2006529A1
- Authority
- CA
- Canada
- Prior art keywords
- loweralkyl
- hydrogen
- medicaments
- preparation
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/289,887 US4868190A (en) | 1988-12-27 | 1988-12-27 | N-pyridinyl-9H-carbazol-9-amines |
US289,887 | 1988-12-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2006529A1 true CA2006529A1 (fr) | 1990-06-27 |
CA2006529C CA2006529C (fr) | 1999-08-10 |
Family
ID=23113557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002006529A Expired - Fee Related CA2006529C (fr) | 1988-12-27 | 1989-12-22 | N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments |
Country Status (19)
Country | Link |
---|---|
US (1) | US4868190A (fr) |
EP (1) | EP0376155B1 (fr) |
JP (1) | JPH0725749B2 (fr) |
KR (1) | KR900009596A (fr) |
AT (1) | ATE79118T1 (fr) |
AU (1) | AU623205B2 (fr) |
CA (1) | CA2006529C (fr) |
DE (1) | DE68902386T2 (fr) |
DK (1) | DK662189A (fr) |
ES (1) | ES2044043T3 (fr) |
FI (1) | FI896243A0 (fr) |
GR (1) | GR3006140T3 (fr) |
IE (1) | IE894175L (fr) |
IL (1) | IL92867A0 (fr) |
NO (1) | NO895222L (fr) |
NZ (1) | NZ231943A (fr) |
PH (1) | PH27122A (fr) |
PT (1) | PT92696A (fr) |
ZA (1) | ZA899904B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4916135A (en) * | 1989-05-08 | 1990-04-10 | Hoechst Roussel Pharmaceuticals Inc. | N-heteroaryl-4-quinolinamines |
US5179099A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 2,3-dihydro-1-(pyridinylamino)-indoles |
US4994472A (en) * | 1989-08-02 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
NZ234726A (en) * | 1989-08-02 | 1992-01-29 | Hoechst Roussel Pharma | 2,3-dihydro-1-(pyridinylamino)-indoles and pharmaceutical compositions |
US4983608A (en) * | 1989-09-05 | 1991-01-08 | Hoechst-Roussell Pharmaceuticals, Inc. | N-substituted-4-pyrimidinamines and pyrimidinediamines |
ES2174081T3 (es) * | 1995-07-27 | 2002-11-01 | Aventis Pharma Inc | Uso de n-(pirrol-1-il)piridinaminas sustituidas y no sustituidas como agentes anticonvulsivos. |
US5776955A (en) * | 1995-07-27 | 1998-07-07 | Hoechst Marion Roussel, Inc. | Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
CZ2003445A3 (cs) * | 2000-07-21 | 2004-08-18 | Ortho@Mcneilápharmaceuticalźáinc | Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7181M (fr) * | 1966-11-16 | 1969-08-11 | ||
EP0073849A1 (fr) * | 1981-09-03 | 1983-03-16 | Schering Corporation | Phényltétrahydro-1,2,3,4 carbazoles, leur préparation et compositions pharmaceutiques les contenant |
US4752610A (en) * | 1985-12-04 | 1988-06-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing properties |
US4792562A (en) * | 1985-12-04 | 1988-12-20 | Hoechst-Roussel Pharmaceuticals, Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing activity |
EP0287982B1 (fr) * | 1987-04-24 | 1994-12-07 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(pyridinyl)-1H-indol-1-amines, leur procédé de préparation et leur utilisation comme médicaments |
US4806554A (en) * | 1988-01-11 | 1989-02-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Pyrazol and indazolpyridinamines |
US4916135A (en) * | 1989-05-08 | 1990-04-10 | Hoechst Roussel Pharmaceuticals Inc. | N-heteroaryl-4-quinolinamines |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
NZ234726A (en) * | 1989-08-02 | 1992-01-29 | Hoechst Roussel Pharma | 2,3-dihydro-1-(pyridinylamino)-indoles and pharmaceutical compositions |
-
1988
- 1988-12-27 US US07/289,887 patent/US4868190A/en not_active Expired - Lifetime
-
1989
- 1989-12-21 DE DE8989123612T patent/DE68902386T2/de not_active Expired - Fee Related
- 1989-12-21 IE IE894175A patent/IE894175L/xx unknown
- 1989-12-21 NZ NZ231943A patent/NZ231943A/en unknown
- 1989-12-21 ES ES89123612T patent/ES2044043T3/es not_active Expired - Lifetime
- 1989-12-21 AT AT89123612T patent/ATE79118T1/de not_active IP Right Cessation
- 1989-12-21 EP EP89123612A patent/EP0376155B1/fr not_active Expired - Lifetime
- 1989-12-22 AU AU47203/89A patent/AU623205B2/en not_active Ceased
- 1989-12-22 CA CA002006529A patent/CA2006529C/fr not_active Expired - Fee Related
- 1989-12-22 FI FI896243A patent/FI896243A0/fi not_active Application Discontinuation
- 1989-12-22 PT PT92696A patent/PT92696A/pt unknown
- 1989-12-22 NO NO89895222A patent/NO895222L/no unknown
- 1989-12-22 DK DK662189A patent/DK662189A/da not_active Application Discontinuation
- 1989-12-25 IL IL92867A patent/IL92867A0/xx unknown
- 1989-12-26 KR KR1019890019472A patent/KR900009596A/ko not_active Application Discontinuation
- 1989-12-26 PH PH39801A patent/PH27122A/en unknown
- 1989-12-26 JP JP1335256A patent/JPH0725749B2/ja not_active Expired - Fee Related
- 1989-12-27 ZA ZA899904A patent/ZA899904B/xx unknown
-
1992
- 1992-11-04 GR GR920402184T patent/GR3006140T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0376155A1 (fr) | 1990-07-04 |
US4868190A (en) | 1989-09-19 |
DE68902386T2 (de) | 1993-02-11 |
CA2006529C (fr) | 1999-08-10 |
AU4720389A (en) | 1990-07-05 |
GR3006140T3 (fr) | 1993-06-21 |
ZA899904B (en) | 1991-02-27 |
DK662189A (da) | 1990-06-28 |
FI896243A0 (fi) | 1989-12-22 |
JPH02247173A (ja) | 1990-10-02 |
EP0376155B1 (fr) | 1992-08-05 |
DE68902386D1 (de) | 1992-09-10 |
JPH0725749B2 (ja) | 1995-03-22 |
DK662189D0 (da) | 1989-12-22 |
KR900009596A (ko) | 1990-07-05 |
IE894175L (en) | 1990-06-27 |
ES2044043T3 (es) | 1994-01-01 |
NZ231943A (en) | 1992-06-25 |
PH27122A (en) | 1993-03-16 |
ATE79118T1 (de) | 1992-08-15 |
IL92867A0 (en) | 1990-09-17 |
NO895222D0 (no) | 1989-12-22 |
PT92696A (pt) | 1990-06-29 |
NO895222L (no) | 1990-06-28 |
AU623205B2 (en) | 1992-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2019957A1 (fr) | Heteroarylamino- et heteroaryloxypyridinamines et composes apparentes, procede de preparation et utilisation en dermatologie | |
AU589029B2 (en) | Alpha-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments | |
CA2006529A1 (fr) | N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments | |
PL313078A1 (en) | Novel bis-naphtalimides for use in treating carcinoma | |
CA2028287A1 (fr) | Benzocycloalkylaminopyridinamines et composes connexes, procede et intermediaires pour leur preparation et leur utilisation comme medicaments | |
HU895830D0 (en) | Process for the preparation of 1,2,3,4-tetrahydro-1,9-acridine-diamines and pharmaceutical compositions containing said compounds | |
AU625221B2 (en) | (1,2,3,4-tetrahydro-9-acridinimino)cyclohexae carboxylic acid and related compounds, a process for their preparation and their use as medicaments | |
CA2003023A1 (fr) | Hydroxy-1,2,3,4-tetrahydroaminoacridines, procede de preparation et utilisation comme medicaments | |
AU619985B2 (en) | 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |